Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Equity: 2019-2025

Historic Return on Equity for Revolution Medicines (RVMD) over the last 6 years, with Sep 2025 value amounting to -0.56%.

  • Revolution Medicines' Return on Equity fell 20.00% to -0.56% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.56%, marking a year-over-year decrease of 20.00%. This contributed to the annual value of -0.29% for FY2024, which is 5.00% up from last year.
  • Revolution Medicines' Return on Equity amounted to -0.56% in Q3 2025, which was down 34.79% from -0.41% recorded in Q2 2025.
  • Revolution Medicines' 5-year Return on Equity high stood at -0.20% for Q2 2021, and its period low was -0.56% during Q3 2025.
  • In the last 3 years, Revolution Medicines' Return on Equity had a median value of -0.32% in 2025 and averaged -0.35%.
  • In the last 5 years, Revolution Medicines' Return on Equity surged by 32bps in 2021 and then dropped by 22bps in 2022.
  • Revolution Medicines' Return on Equity (Quarterly) stood at -0.30% in 2021, then decreased by 6bps to -0.36% in 2022, then grew by 4bps to -0.33% in 2023, then climbed by 1bps to -0.31% in 2024, then dropped by 20bps to -0.56% in 2025.
  • Its Return on Equity stands at -0.56% for Q3 2025, versus -0.41% for Q2 2025 and -0.32% for Q1 2025.